With today's current focus on patient safety and medication administration, the ISMP and JCAHO have identified several consistently problematic areas for PCA use: PCA has been used successfully with ...

A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment ...

Targeting prostate cancer (PCa) neuroendocrine (NE) cells via inhibition of the C-X-C motif chemokine receptor 2 (CXCR2) is an androgen receptor (AR)-independent therapeutic strategy that can improve ...

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries ...

Nearly one quarter of men with stage IV prostate cancer (PCa) receive no treatment for the malignancy, data show. Eberechukwu Onukwugha, PhD, of the University of Maryland School of Pharmacy in ...

Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment ...